Novel streptococcus antigens

Details for Australian Patent Application No. 2008229967 (hide)

Owner ID Biomedical Corporation of Quebec

Inventors Hamel, Josee; Brodeur, Bernard R.; Pineau, Isabelle; Martin, Denis; Rioux, Clement; Charland, Nathalie

Agent Griffith Hack

Pub. Number AU-B-2008229967

Parent 2005209689

Filing date 16 October 2008

Wipo publication date 6 November 2008

Acceptance publication date 5 July 2012

International Classifications

C12N 15/31 Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/09 Medicinal preparations containing antigens or antibodies - Streptococcus

C07K 14/315 Peptides having more than 20 amino acids

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

6 November 2008 Application Open to Public Inspection

  Published as AU-B-2008229967

6 November 2008 Complete Application Filed

28 June 2012 Alteration of Name

  The name of the applicant has been altered to ID Biomedical Corporation of Quebec

5 July 2012 Application Accepted

  Published as AU-B-2008229967

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008229968-Polypeptide variants with altered effector function

2008229966-Radome with polyester-polyarylate fibers and a method of making same